164 related articles for article (PubMed ID: 36129146)
1. Claudin‑9 is a novel prognostic biomarker for endometrial cancer.
Endo Y; Sugimoto K; Kobayashi M; Kobayashi Y; Kojima M; Furukawa S; Soeda S; Watanabe T; Higashi AY; Higashi T; Hashimoto Y; Fujimori K; Chiba H
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36129146
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Significance of Aberrant Claudin-6 Expression in Endometrial Cancer.
Kojima M; Sugimoto K; Tanaka M; Endo Y; Kato H; Honda T; Furukawa S; Nishiyama H; Watanabe T; Soeda S; Fujimori K; Chiba H
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32987797
[TBL] [Abstract][Full Text] [Related]
3. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
4. Expression of Claudin-9 (CLDN9) in Breast Cancer, the Clinical Significance in Connection with Its Subcoat Anchorage Proteins ZO-1 and ZO-3 and Impact on Drug Resistance.
Zhuang X; Martin TA; Ruge F; Zeng JJ; Li XA; Khan E; Dou Q; Davies E; Jiang WG
Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137355
[TBL] [Abstract][Full Text] [Related]
5. Identification of Claudin-6 as a Molecular Biomarker in Pan-Cancer Through Multiple Omics Integrative Analysis.
Zhang C; Guo C; Li Y; Liu K; Zhao Q; Ouyang L
Front Cell Dev Biol; 2021; 9():726656. PubMed ID: 34409042
[TBL] [Abstract][Full Text] [Related]
6. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
[TBL] [Abstract][Full Text] [Related]
7. Claudin-9 enhances the metastatic potential of hepatocytes via Tyk2/Stat3 signaling.
Liu H; Wang M; Liang N; Guan L
Turk J Gastroenterol; 2019 Aug; 30(8):722-731. PubMed ID: 31418417
[TBL] [Abstract][Full Text] [Related]
8. Aberrantly activated claudin 6 and 18.2 as potential therapy targets in non-small-cell lung cancer.
Micke P; Mattsson JS; Edlund K; Lohr M; Jirström K; Berglund A; Botling J; Rahnenfuehrer J; Marincevic M; Pontén F; Ekman S; Hengstler J; Wöll S; Sahin U; Türeci O
Int J Cancer; 2014 Nov; 135(9):2206-14. PubMed ID: 24710653
[TBL] [Abstract][Full Text] [Related]
9. High expression of S100A2 predicts poor prognosis in patients with endometrial carcinoma.
Zhang Q; Xia T; Qi C; Du J; Ye C
BMC Cancer; 2022 Jan; 22(1):77. PubMed ID: 35042454
[TBL] [Abstract][Full Text] [Related]
10. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
11. The correlation among Claudin-9, Tyrosine kinase-2, and Signal transducers and activators of transcription-3 expressions in non-functioning pituitary adenoma and invasiveness.
Yasen A; Tuoheti M; Tu B; Zhang C; Ding Y; Tang F; Wu Y
Neuro Endocrinol Lett; 2023 Dec; 44(8):537-546. PubMed ID: 38131177
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the cell adhesion molecule claudin-9 is associated with invasion in pituitary oncocytomas.
Hong L; Wu Y; Feng J; Yu S; Li C; Wu Y; Li Z; Cao L; Wang F; Zhang Y
Hum Pathol; 2014 Dec; 45(12):2423-9. PubMed ID: 25281028
[TBL] [Abstract][Full Text] [Related]
13. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
14. Possibility of Targeting Claudin-2 in Therapy for Human Endometrioid Endometrial Carcinoma.
Okada T; Konno T; Kohno T; Shimada H; Saito K; Satohisa S; Saito T; Kojima T
Reprod Sci; 2020 Nov; 27(11):2092-2103. PubMed ID: 32548807
[TBL] [Abstract][Full Text] [Related]
15. The mRNA of claudins is expressed in the endolymphatic sac epithelia.
Matsubara A; Miyashita T; Mori T; Akiyama K; Inamoto R; Mori N
Auris Nasus Larynx; 2012 Aug; 39(4):361-4. PubMed ID: 21871748
[TBL] [Abstract][Full Text] [Related]
16. Antibody specificity against highly conserved membrane protein Claudin 6 driven by single atomic contact point.
Screnci B; Stafford LJ; Barnes T; Shema K; Gilman S; Wright R; Al Absi S; Phillips T; Azuelos C; Slovik K; Murphy P; Harmon DB; Charpentier T; Doranz BJ; Rucker JB; Chambers R
iScience; 2022 Dec; 25(12):105665. PubMed ID: 36505931
[TBL] [Abstract][Full Text] [Related]
17. Claudin 6: Therapeutic prospects for tumours, and mechanisms of expression and regulation (Review).
Du H; Yang X; Fan J; Du X
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34296304
[TBL] [Abstract][Full Text] [Related]
18. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue.
Pan XY; Wang B; Che YC; Weng ZP; Dai HY; Peng W
Int J Gynecol Cancer; 2007; 17(1):233-41. PubMed ID: 17291259
[TBL] [Abstract][Full Text] [Related]
19. Expression of claudins-1, -4, -5, -7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients' survival.
Bouchagier KA; Assimakopoulos SF; Karavias DD; Maroulis I; Tzelepi V; Kalofonos H; Karavias DD; Kardamakis D; Scopa CD; Tsamandas AC
In Vivo; 2014; 28(3):315-26. PubMed ID: 24815833
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of miR-205 in endometrial cancer.
Karaayvaz M; Zhang C; Liang S; Shroyer KR; Ju J
PLoS One; 2012; 7(4):e35158. PubMed ID: 22514717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
